SHARP PHILLIP A

Insider Buys Quantity –
2
2024-02-29SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
30,000
0.0241%
$151.34$4.54M-0.76%
2022-08-15SaleAlnylam Pharmaceuticals, Inc.
ALNY
16,186
0.0132%
$230.71$3.73M-12.2%
2022-02-09SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
30,000
0.0247%
$150.00$4.5M+27.46%
2020-11-25SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
30,000
0.026%
$124.89$3.75M+31.65%
2020-02-12SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
30,000
0.0258%
$130.00$3.9M+1.36%
2019-11-18SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
15,000
0.0133%
$91.71$1.38M+40.9%
2019-04-15SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
30,000
0.0275%
$88.23$2.65M-1.54%
2018-03-13SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
30,000
0.031%
$149.00$4.47M-35.36%
2018-03-09SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
30,000
0.0291%
$129.00$3.87M-29.67%
2017-02-01SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
50,000
0.0572%
$39.80$1.99M+100.87%
2017-01-25SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
30,000
0.035%
$37.95$1.14M+112.64%
2017-01-18SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
30,000
0.0343%
$37.83$1.13M+107.21%
2015-12-04SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
60,000
0.0707%
$109.00$6.54M-39.9%
2014-10-13SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
220,000
0.2904%
$85.00$18.7M+20.46%
2013-01-22PurchaseAlnylam Pharmaceuticals, Inc.
ALNY
director
9,934
0.0144%
$20.13$199,971+95.51%
2012-02-21PurchaseAlnylam Pharmaceuticals, Inc.
ALNY
director
18,604
0.0361%
$10.75$199,993+41.4%
2008-07-21SaleBiogen Inc.
BIIB
director
72,500
0.0132%
$35.42$2.57M-27.26%
2008-04-08SaleBiogen Inc.
BIIB
director
99,900
0.0264%
$49.95$4.99M-22.7%
2004-05-14SaleBiogen Inc.
BIIB
director
294,100
0.088%
$58.96$17.34M+2%
2004-05-13SaleBiogen Inc.
BIIB
director
65,000
0.0039%
$11.73$762,450+2.02%